Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
OR | (95% CI) | P value | OR | (95% CI) | P value | |
Sex | ||||||
Female | 1.8 | (0.81–4.00) | 0.132 | |||
Male | 1 | |||||
History of liver cancer | ||||||
Yes | 6.37 | (1.86–23.60) | 0.001 | 2.05 | (0.37–11.40) | 0.411 |
No | 1 | 1 | ||||
History on non-liver malignancy | ||||||
Yes | 3.01 | (0.88–9.93) | 0.054 | |||
No | 1 | |||||
Dyslipidemia | ||||||
Yes | 1.68 | (0.72–3.83) | 0.220 | |||
No | 1 | |||||
Hypertension | ||||||
Yes | 1.55 | (0.68–3.49) | 0.323 | |||
No | 1 | |||||
Hyperuricemia | ||||||
Yes | 2.37 | (0.19–21.56) | 0.311 | |||
No | 1 | |||||
Smoking | ||||||
No | 1.22 | (0.46–3.66) | 0.821 | |||
Yes | 1 | |||||
Gamma-glutamyl transpeptidase (IU/L) | ||||||
< 71 | 1.35 | (0.62–3.00) | 0.464 | |||
≥ 71 | 1 | |||||
Hemoglobin (g/dL) | ||||||
≤ 14.5 | 2.16 | (0.97–5.03) | 0.045 | 1.37 | (0.43–4.36) | 0.594 |
> 14.5 | 1 | 1 | ||||
Ferritin (ng/mL) | ||||||
≥ 180 | 1.16 | (0.52–2.61) | 0.711 | |||
< 180 | ||||||
NAFLD fibrosis score | ||||||
≥ − 1.455 | 16.49 | (6.43–47.12) | < 0.01 | 14.60 | (4.50–47.20) | < 0.01 |
< − 1.455 | 1 | 1 | ||||
PNPLA3 rs738409 | ||||||
GG | 3.13 | (1.18–8.74) | 0.014 | 1.78 | (0.58–5.44) | 0.312 |
Non GG | 1 | 1 | ||||
TM6SF2 rs58542926 | ||||||
Non CC | 1.24 | (0.41–3.53) | 0.802 | |||
CC | 1 | |||||
HSD17B13 rs6834314 | ||||||
Non AA | 1.43 | (0.54–3.94) | 0.506 | |||
AA | 1 |